Noida, India — 15 January, 2026 – Ikris Pharma Network announced the availability of Triokris™ (Trientine Dihydrochloride 250 mg Capsules), a therapeutic option for patients diagnosed...
CureAble, a Delhi-based Healthcare startup, focusing on personalized therapies for special-needs children, has raised Rs2 crore in a pre-seed round from a US-based investment firm Brahma...